Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Testing effectiveness (Phase 2)WithdrawnNCT05898828What this trial is testingPhase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal CancerWho this might be right forNeoplasmsEsophageal NeoplasmsEsophagus Neoplasm+3 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07432295What this trial is testingGivastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)Who this might be right forSolid TumorAdvanced CancerMetastatic Cancer+3 more I-Mab Biopharma US Limited 180
Early research (Phase 1)Study completedNCT04837677What this trial is testingPRT1419 in Patients With Advanced Solid TumorsWho this might be right forSarcomaMelanomaLung Cancer+4 more Prelude Therapeutics Incorporated 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT06251973What this trial is testingAgenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction CancerWho this might be right forMetastatic Esophageal CarcinomaAdvanced Unresectable Gastric AdenocarcinomaMetastatic Gastric Cancer+10 more Memorial Sloan Kettering Cancer Center 20
Early research (Phase 1)Ended earlyNCT03854227What this trial is testingA Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Solid Tumors Pfizer 54
Testing effectiveness (Phase 2)Looking for participantsNCT06846346What this trial is testingTesting Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal AdenocarcinomaWho this might be right forMetastatic Esophageal AdenocarcinomaAdvanced Esophageal AdenocarcinomaMetastatic Gastric Adenocarcinoma+1 more UNICANCER 88
Testing effectiveness (Phase 2)Looking for participantsNCT06586242What this trial is testingEfficacy and Safety of Penpulimab Combined With Anlotinib and ChemotherapyWho this might be right forEsophageal Cancer Xijing Hospital 194
Early research (Phase 1)Study completedNCT02318329What this trial is testingOpen-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsGastric CancerTransitional Cell Carcinoma of the Bladder Five Prime Therapeutics, Inc. 79
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Looking for participantsNCT07038629What this trial is testingChemoradiation Plus Iparomlimab Consolidation in Older With ESCCWho this might be right forEsophageal Cancer Tianjin Medical University Cancer Institute and Hospital 52
Early research (Phase 1)Looking for participantsNCT04900818What this trial is testingStudy of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsWho this might be right forSolid TumorAdvanced CancerMetastatic Cancer+5 more I-Mab Biopharma US Limited 330
Not applicableUnknownNCT04471480What this trial is testingTC Plus PD-1 Inhibitors Combined With Anlotinib for Advanced Advanced Esophageal CancerWho this might be right forESCC Dong Wang 90
Testing effectiveness (Phase 2)UnknownNCT00005876What this trial is testingNitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During SurgeryWho this might be right forEsophageal CancerGastric Cancer Astex Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT05057013What this trial is testingA Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursWho this might be right forBladder CancerTriple Negative Breast CancerCastration-resistant Prostate Cancer+11 more Cancer Research UK 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT06143748What this trial is testingCombination of Cadonilimab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-006)Who this might be right forEsophagus Cancer Sun Yat-sen University 46
Testing effectiveness (Phase 2)Study completedNCT00633789What this trial is testingPhase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor TypesWho this might be right forAdvanced Non-small Cell Lung CancerTransitional Cell CarcinomaSoft Tissue Sarcoma+2 more Bristol-Myers Squibb 597
Not applicableUnknownNCT03671265What this trial is testingCombination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCCWho this might be right forEsophageal Cancer Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06469944What this trial is testingSubstudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)Who this might be right forGastroesophageal JunctionGastroesophageal AdenocarcinomaEsophageal Neoplasms+1 more Merck Sharp & Dohme LLC 160
Large-scale testing (Phase 3)Study completedNCT03143153What this trial is testingEvaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus CisplatinWho this might be right forVarious Advanced Cancer Bristol-Myers Squibb 970